BNP Paribas Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $169M | Sell |
2,104,677
-80,976
| -4% | -$6.68M | 0.2% | 109 |
|
|
2025
Q4 | $186M | Buy |
2,185,653
+436,200
| +25% | +$35.8M | 0.21% | 92 |
|
|
2025
Q3 | $136M | Buy |
1,749,453
+134,850
| +8% | +$10.5M | 0.35% | 53 |
|
|
2025
Q2 | $126M | Buy |
1,614,603
+272,762
| +20% | +$20.3M | 0.31% | 65 |
|
|
2025
Q1 | $97.3M | Buy |
1,341,841
+224,531
| +20% | +$16.1M | 0.26% | 91 |
|
|
2024
Q4 | $82.7M | Buy |
1,117,310
+73,549
| +7% | +$5.15M | 0.21% | 109 |
|
|
2024
Q3 | $68.9M | Sell |
1,043,761
-6,628
| -0.6% | -$482K | 0.17% | 134 |
|
|
2024
Q2 | $97M | Sell |
1,050,389
-130,079
| -11% | -$11.5M | 0.25% | 88 |
|
|
2024
Q1 | $113M | Sell |
1,180,468
-36,645
| -3% | -$3.08M | 0.3% | 72 |
|
|
2023
Q4 | $92.8M | Sell |
1,217,113
-338,074
| -22% | -$23.5M | 0.26% | 99 |
|
|
2023
Q3 | $108M | Sell |
1,555,187
-132,796
| -8% | -$10.7M | 0.33% | 70 |
|
|
2023
Q2 | $159M | Buy |
1,687,983
+374,985
| +29% | +$32.6M | 0.49% | 40 |
|
|
2023
Q1 | $109M | Buy |
1,312,998
+100,656
| +8% | +$7.91M | 0.38% | 57 |
|
|
2022
Q4 | $90.5M | Sell |
1,212,342
-38,601
| -3% | -$2.97M | 0.32% | 73 |
|
|
2022
Q3 | $103M | Buy |
1,250,943
+36,467
| +3% | +$3.51M | 0.41% | 52 |
|
|
2022
Q2 | $115M | Buy |
1,214,476
+174,144
| +17% | +$18M | 0.44% | 44 |
|
|
2022
Q1 | $122M | Buy |
1,040,332
+195,893
| +23% | +$22M | 0.43% | 46 |
|
|
2021
Q4 | $109M | Sell |
844,439
-83,548
| -9% | -$9.75M | 0.37% | 58 |
|
|
2021
Q3 | $105M | Sell |
927,987
-69,147
| -7% | -$7.89M | 0.39% | 55 |
|
|
2021
Q2 | $103M | Buy |
997,134
+75,623
| +8% | +$7.13M | 0.37% | 56 |
|
|
2021
Q1 | $77.1M | Buy |
921,511
+28,930
| +3% | +$2.45M | 0.32% | 72 |
|
|
2020
Q4 | $81.4M | Buy |
892,581
+90,085
| +11% | +$7.47M | 0.38% | 57 |
|
|
2020
Q3 | $64.1M | Sell |
802,496
-153,703
| -16% | -$12M | 0.36% | 61 |
|
|
2020
Q2 | $66.1M | Sell |
956,199
-16,392
| -2% | -$1.16M | 0.45% | 48 |
|
|
2020
Q1 | $61.1M | Buy |
972,591
+212,334
| +28% | +$15.3M | 0.52% | 34 |
|
|
2019
Q4 | $59.1M | Sell |
760,257
-27,570
| -3% | -$2.15M | 0.4% | 49 |
|
|
2019
Q3 | $57.8M | Buy |
787,827
+26,592
| +3% | +$1.87M | 0.44% | 45 |
|
|
2019
Q2 | $46.9M | Buy |
761,235
+107,424
| +16% | +$6.5M | 0.38% | 63 |
|
|
2019
Q1 | $41.7M | Sell |
653,811
-100,806
| -13% | -$5.75M | 0.35% | 60 |
|
|
2018
Q4 | $37.8M | Sell |
754,617
-53,604
| -7% | -$2.71M | 0.35% | 62 |
|
|
2018
Q3 | $46.9M | Sell |
808,221
-2,262
| -0.3% | -$111K | 0.36% | 67 |
|
|
2018
Q2 | $39.3M | Sell |
810,483
-309,855
| -28% | -$14.5M | 0.33% | 71 |
|
|
2018
Q1 | $52.1M | Sell |
1,120,338
-467,826
| -29% | -$20.3M | 0.44% | 36 |
|
|
2017
Q4 | $59.7M | Sell |
1,588,164
-37,935
| -2% | -$1.39M | 0.51% | 28 |
|
|
2017
Q3 | $59.2M | Buy |
1,626,099
+230,262
| +16% | +$8.78M | 0.5% | 36 |
|
|
2017
Q2 | $55M | Sell |
1,395,837
-396,666
| -22% | -$14.5M | 0.49% | 37 |
|
|
2017
Q1 | $56.2M | Buy |
1,792,503
+378,264
| +27% | +$11.8M | 0.52% | 38 |
|
|
2016
Q4 | $44.2M | Buy |
1,414,239
+477,489
| +51% | +$15.5M | 0.42% | 53 |
|
|
2016
Q3 | $37.6M | Sell |
936,750
-647,157
| -41% | -$24.4M | 0.32% | 66 |
|
|
2016
Q2 | $52.7M | Buy |
1,583,907
+156,168
| +11% | +$5.34M | 0.44% | 48 |
|
|
2016
Q1 | $42M | Buy |
1,427,739
+745,341
| +109% | +$20.6M | 0.36% | 66 |
|
|
2015
Q4 | $18M | Buy |
682,398
+302,406
| +80% | +$7.85M | 0.15% | 176 |
|
|
2015
Q3 | $9M | Sell |
379,992
-13,326
| -3% | -$322K | 0.08% | 327 |
|
|
2015
Q2 | $9.34M | Buy |
393,318
+221,394
| +129% | +$5M | 0.08% | 347 |
|
|
2015
Q1 | $4.08M | Buy |
171,924
+67,698
| +65% | +$1.52M | 0.03% | 548 |
|
|
2014
Q4 | $2.21M | Buy |
104,226
+11,208
| +12% | +$225K | 0.02% | 599 |
|
|
2014
Q3 | $1.58M | Buy |
93,018
+1,002
| +1% | +$15.8K | 0.01% | 659 |
|
|
2014
Q2 | $1.32M | Sell |
92,016
-576
| -0.6% | -$7.81K | 0.01% | 725 |
|
|
2014
Q1 | $1.15M | Buy |
92,592
+44,742
| +94% | +$516K | 0.01% | 746 |
|
|
2013
Q4 | $524K | Sell |
47,850
-4,626
| -9% | -$52.1K | ﹤0.01% | 766 |
|
|
2013
Q3 | $609K | Buy |
+52,476
| New | +$614K | ﹤0.01% | 745 |
|
Other funds holding EW
VCM
VPM
BNP Paribas Asset Management's EW Position: Q1 2026 in Review
BNP Paribas Asset Management reduced its Edwards Lifesciences (EW) stake by 3.7% in Q1 2026, selling an estimated $6.68M and leaving 2,104,677 shares worth $169M. The position accounts for 0.2% of the portfolio, ranked #109.
BNP Paribas Asset Management first reported a position in EW in Q3 2013 and has held it in 51 quarters since. The position peaked at $186M in Q4 2025. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- BNP Paribas Asset Management held 2,104,677 shares of Edwards Lifesciences worth $169M as of Q1 2026.
- BNP Paribas Asset Management sold 80,976 Edwards Lifesciences shares in Q1 2026, an estimated $6.68M.
- Edwards Lifesciences made up 0.2% of BNP Paribas Asset Management's portfolio in Q1 2026, its #109 holding.
- BNP Paribas Asset Management first reported a position in Edwards Lifesciences in Q3 2013 and has held it in 51 quarters since.
- BNP Paribas Asset Management's Edwards Lifesciences position peaked at $186M in Q4 2025.
- 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.